FindTrial
Sign In

To evaluate safety and benefit of Ahaglow (GlycOlic acid, Aloe veRa and Vitamin-E) based face wash for daily use in Acne Prone Skin

A Patient Reported Outcome Study to Assess Clinical Impact, Utilization and Safety of Glycolic Acid, Aloe VeRA and Vitamin - E based face wash for daily use in Acne Prone Skin (AUORA)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053763
Enrollment
3000
Registered
2023-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L709- Acne, unspecified

Interventions

Intervention1: Face Wash: Glycolic Acid, Aloe Vera, Vitamin E Face Wash ( AhaGlow Face Wash) to apply for 4 weeks Control Intervention1: Not Applicable: Not Applicable

Sponsors

Torrent Pharmaceuticals Ltd,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients suffering from acne skin conditions currently receiving medical management as tretinoin or adapalene with or without BPO. 2) Clinical cases requiring complementary add on or maintenance therapy.

Exclusion criteria

Exclusion criteria: 1) Allergic skin diseases other than cases of Acne.

Design outcomes

Primary

MeasureTime frame
Safety Assessment - Incidence of treatment emergent adverse events (TEAEs) [i.e.Safety and Tolerability] occurring during the course of treatment will be recorded for safety parameter. Timepoint: At 4 weeks—

Secondary

MeasureTime frame
Patient assessed outcomes for Quality of lifeTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Rathish Nair PhD MBA

Torrent Pharmaceuticals Ltd

krishnaprasadkorukonda@torrentpharma.com7069000572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026